drugset / Trial / NCT04137432

Oxytocin-augmented Cognitive-behavioral Group-based Short-term Intervention for Loneliness

NCT04137432

RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to evaluate the clinical potential of oxytocin (OT) as an adjunct to a cognitive-behavioral group-based shortterm intervention for participants suffering from loneliness.

Timeline

Start
2019-09-26
Primary completion
2020-09
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 24 iu Intranasal

Indications

No indication recorded.